Tagged with Michael Good

Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.

As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.

Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.

Griffith University researchers have unlocked one of the secrets as to why some forms of Strep A are associated with severe invasive infection.

Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.

A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.

Broad-spectrum malaria vaccine can be freeze-dried making it suitable for deployment into malaria-endemic countries.